Christopher J. Kirk - Jul 20, 2023 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role
Director
Signature
/s/ Marc Belsky, Attorney-in-fact
Stock symbol
KZR
Transactions as of
Jul 20, 2023
Transactions value $
$44,055
Form type
4
Date filed
7/24/2023, 04:20 PM
Previous filing
Jan 10, 2023
Next filing
Jul 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KZR Common Stock Options Exercise $44.1K +49K +12.8% $0.90 431K Jul 20, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KZR Employee Stock Option (right to buy) Options Exercise $0 -49K -39.68% $0.00 74.4K Jul 20, 2023 Common Stock 49K $0.90 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Total reflects 914 shares of common stock acquired on November 15, 2022 through the Company's 2018 Employee Stock Purchase Plan.
F2 Fully vested and exercisable.